Halozyme Therapeutics reported $787.26M in Loan Capital for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.28M 0.28M
Aptinyx Inc APTX:US $ 24.29M 10.14M
Cytokinetics CYTK:US $ 197.08M 54.24M
Intrexon XON:US $ 179.82M 2.9M
IONIS PHARMACEUT IONS:US $ 1247M 5.31M
Minerva Neurosciences NERV:US $ 0M 0M
Peregrine Pharmaceuticals PPHM:US $ 141.33M 2.52M